Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma

NCT02444949 is registered in ClinicalTrials.gov with China Three Gorges University, Yichang, China as lead sponsor.

NCT NCT02444949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02444949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
Lead sponsor
China Three Gorges University, Yichang, China
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2014
Completion date
December 31, 2019
Enrollment
75 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal neoplasms